2825 related articles for article (PubMed ID: 26277463)
1. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
3. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
4. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
5. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
[TBL] [Abstract][Full Text] [Related]
7. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
8. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
[TBL] [Abstract][Full Text] [Related]
9. Beyond the learning curve: transapical versus transfemoral transcatheter aortic valve replacement in the treatment of severe aortic valve stenosis.
Greason KL; Suri RM; Nkomo VT; Rihal CS; Holmes DR; Mathew V
J Card Surg; 2014 May; 29(3):303-7. PubMed ID: 24601949
[TBL] [Abstract][Full Text] [Related]
10. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
[TBL] [Abstract][Full Text] [Related]
11. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
12. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
[TBL] [Abstract][Full Text] [Related]
13. Massive aortic regurgitation following paravalvular balloon valvuloplasty of an Edwards SAPIEN valve treated by emergent CoreValve implantation: never cross a transcatheter aortic valve without a pigtail.
Noble S; Cikirikcioglu M; Roffi M
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E609-12. PubMed ID: 23460365
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
16. Balloon-expandable transaortic transcatheter aortic valve implantation with or without predilation.
Bonaros N; Kofler M; Frank D; Cocchieri R; Jagielak D; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Bapat V; Rein KA; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Romano M
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):915-923. PubMed ID: 29221741
[TBL] [Abstract][Full Text] [Related]
17. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
[TBL] [Abstract][Full Text] [Related]
19. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
